Zum Hauptinhalt springen

Direct activation of Ca <superscript>2+</superscript> and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor.

Bondarenko, AI ; Panasiuk, O ; et al.
In: European journal of pharmacology, Jg. 805 (2017-06-15), S. 14-24
Online academicJournal

Titel:
Direct activation of Ca <superscript>2+</superscript> and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor.
Autor/in / Beteiligte Person: Bondarenko, AI ; Panasiuk, O ; Okhai, I ; Montecucco, F ; Brandt, KJ ; Mach, F
Link:
Zeitschrift: European journal of pharmacology, Jg. 805 (2017-06-15), S. 14-24
Veröffentlichung: 2005- : Amsterdam : Elsevier Science ; <i>Original Publication</i>: Amsterdam, North Holland Pub. Co., 2017
Medientyp: academicJournal
ISSN: 1879-0712 (electronic)
DOI: 10.1016/j.ejphar.2017.03.038
Schlagwort:
  • Calcium metabolism
  • Cell Membrane drug effects
  • Cell Membrane metabolism
  • Cholesterol metabolism
  • Human Umbilical Vein Endothelial Cells cytology
  • Humans
  • Ion Channel Gating drug effects
  • Receptors, Cannabinoid metabolism
  • Arachidonic Acids pharmacology
  • Endocannabinoids pharmacology
  • Human Umbilical Vein Endothelial Cells drug effects
  • Human Umbilical Vein Endothelial Cells metabolism
  • Large-Conductance Calcium-Activated Potassium Channels metabolism
  • Polyunsaturated Alkamides pharmacology
  • Potassium Channels, Voltage-Gated metabolism
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article
  • Language: English
  • [Eur J Pharmacol] 2017 Jun 15; Vol. 805, pp. 14-24. <i>Date of Electronic Publication: </i>2017 Mar 19.
  • MeSH Terms: Arachidonic Acids / *pharmacology ; Endocannabinoids / *pharmacology ; Human Umbilical Vein Endothelial Cells / *drug effects ; Human Umbilical Vein Endothelial Cells / *metabolism ; Large-Conductance Calcium-Activated Potassium Channels / *metabolism ; Polyunsaturated Alkamides / *pharmacology ; Potassium Channels, Voltage-Gated / *metabolism ; Calcium / metabolism ; Cell Membrane / drug effects ; Cell Membrane / metabolism ; Cholesterol / metabolism ; Human Umbilical Vein Endothelial Cells / cytology ; Humans ; Ion Channel Gating / drug effects ; Receptors, Cannabinoid / metabolism
  • References: Br J Pharmacol. 1999 Jan;126(1):19-26. (PMID: 10051116) ; Br J Pharmacol. 1999 Apr;126(7):1593-600. (PMID: 10323591) ; Gen Physiol Biophys. 1999 Jun;18(2):199-208. (PMID: 10517293) ; Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41. (PMID: 10570211) ; Biochem J. 2000 Mar 15;346 Pt 3:835-40. (PMID: 10698714) ; Circ Res. 2001 Jul 20;89(2):174-9. (PMID: 11463725) ; Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H908-17. (PMID: 11834486) ; Mol Pharmacol. 2003 Mar;63(3):699-705. (PMID: 12606780) ; Br J Pharmacol. 2003 Nov;140(5):790-801. (PMID: 14517174) ; Circ Res. 2003 Oct 31;93(9):839-47. (PMID: 14551243) ; Pflugers Arch. 2004 Jan;447(4):426-35. (PMID: 14648123) ; J Pharm Pharmacol. 2004 Jul;56(7):869-75. (PMID: 15233865) ; Br J Pharmacol. 2004 Sep;143(1):9-18. (PMID: 15289290) ; J Gen Physiol. 2005 Mar;125(3):273-86. (PMID: 15738049) ; Am J Physiol Cell Physiol. 2006 Jan;290(1):C77-86. (PMID: 16107501) ; Handb Exp Pharmacol. 2005;(168):1-51. (PMID: 16596770) ; Br J Pharmacol. 2006 Dec;149(7):958-65. (PMID: 17001300) ; J Immunol. 2006 Oct 15;177(8):4971-80. (PMID: 17015679) ; Stroke. 2007 Jul;38(7):2136-41. (PMID: 17525390) ; Br J Pharmacol. 2007 Dec;152(7):1092-101. (PMID: 17876302) ; Eur J Pharmacol. 2008 May 13;585(2-3):256-60. (PMID: 18423600) ; J Cell Sci. 2008 May 15;121(Pt 10):1704-1717. (PMID: 18445684) ; Eur J Pharmacol. 2009 Jan 5;602(1):105-11. (PMID: 19028489) ; FASEB J. 2009 Apr;23(4):1138-45. (PMID: 19074509) ; Atherosclerosis. 2009 Aug;205(2):433-41. (PMID: 19187936) ; Pharmacol Res. 2009 Aug;60(2):85-92. (PMID: 19428268) ; J Mol Cell Cardiol. 2010 Jan;48(1):201-10. (PMID: 19616555) ; Cardiovasc Res. 2010 Jan 1;85(1):56-67. (PMID: 19689982) ; Br J Pharmacol. 2010 Jun;160(3):574-84. (PMID: 20105178) ; Br J Pharmacol. 2010 Jun;160(3):594-603. (PMID: 20136843) ; Curr Med Chem. 2010;17(14):1487-99. (PMID: 20166920) ; Br J Pharmacol. 2010 Sep;161(2):308-20. (PMID: 20735417) ; Pflugers Arch. 2011 Jan;461(1):177-89. (PMID: 21072666) ; Br J Pharmacol. 2011 Aug;163(7):1379-90. (PMID: 21323908) ; Front Physiol. 2010 Oct 29;1:140. (PMID: 21423380) ; J Smooth Muscle Res. 2010;46(6):281-91. (PMID: 21441716) ; Pflugers Arch. 2011 Aug;462(2):245-55. (PMID: 21603896) ; Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2410-23. (PMID: 21868700) ; J Mol Cell Cardiol. 2011 Dec;51(6):1007-14. (PMID: 21884703) ; PLoS One. 2011;6(11):e27572. (PMID: 22140451) ; Pflugers Arch. 2012 Apr;463(5):669-77. (PMID: 22415212) ; J Biol Chem. 2012 Jun 8;287(24):20509-21. (PMID: 22474334) ; Pharmacol Res. 2012 Sep;66(3):251-9. (PMID: 22627170) ; Eur J Pharmacol. 2012 Sep 5;690(1-3):60-7. (PMID: 22760070) ; Curr Med Chem. 2013;20(1):64-78. (PMID: 23151004) ; Br J Pharmacol. 2013 Jun;169(4):834-43. (PMID: 23461720) ; Br J Pharmacol. 2013 Jun;169(4):933-48. (PMID: 23517055) ; Am J Physiol Heart Circ Physiol. 2013 Jun 1;304(11):H1415-27. (PMID: 23542921) ; Pflugers Arch. 2014 Jul;466(7):1411-20. (PMID: 24162235) ; J Pharmacol Exp Ther. 2014 Apr;349(1):29-38. (PMID: 24431468) ; Pflugers Arch. 2014 Dec;466(12):2205-14. (PMID: 24627154) ; Cell Calcium. 2014 May;55(5):231-7. (PMID: 24674601) ; Eur J Pharmacol. 2014 Jul 15;735:105-14. (PMID: 24751709) ; Br J Pharmacol. 2014 Jul;171(14):3485-98. (PMID: 24758718) ; FASEB J. 1989 Oct;3(12):2389-400. (PMID: 2477294) ; Br J Pharmacol. 2014 Dec;171(24):5573-88. (PMID: 25073723) ; Pflugers Arch. 2015 Jun;467(6):1143-64. (PMID: 25106481) ; Methods Mol Biol. 2015;1232:91-102. (PMID: 25331130) ; Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4029-37. (PMID: 26098470) ; Eur J Pharmacol. 2015 Oct 15;765:107-14. (PMID: 26297305) ; Thromb Haemost. 2016 Oct 28;116(5):987-997. (PMID: 27465665) ; Vascul Pharmacol. 2017 Feb;89:39-48. (PMID: 28064014) ; Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7. (PMID: 6407019) ; J Physiol. 1993 Mar;462:735-51. (PMID: 8331598) ; Hypertension. 1999 Jan;33(1 Pt 2):429-34. (PMID: 9931142)
  • Grant Information: 152578 Switzerland SNSF_ Swiss National Science Foundation; P 27238 Austria FWF_ Austrian Science Fund FWF
  • Contributed Indexing: Keywords: Anandamide; BK(Ca) channels; Endothelial cannabinoid receptor; Integrins
  • Substance Nomenclature: 0 (Arachidonic Acids) ; 0 (Endocannabinoids) ; 0 (Large-Conductance Calcium-Activated Potassium Channels) ; 0 (Polyunsaturated Alkamides) ; 0 (Potassium Channels, Voltage-Gated) ; 0 (Receptors, Cannabinoid) ; 97C5T2UQ7J (Cholesterol) ; SY7Q814VUP (Calcium) ; UR5G69TJKH (anandamide)
  • Entry Date(s): Date Created: 20170323 Date Completed: 20171108 Latest Revision: 20220129
  • Update Code: 20240513
  • PubMed Central ID: PMC6520242

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -